Cargando…

Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E

BACKGROUND: Background: Contaminated hospital room environmental surfaces and noncritical medical devices are a potential source of transmission of healthcare pathogens including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Technologies that provide continuous decontamination betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutala, William A., Ikner, Luisa, Donskey, Curtis, Weber, David J., Gerba, Chuck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236725/
http://dx.doi.org/10.1016/j.ajic.2021.04.015
_version_ 1783714600360869888
author Rutala, William A.
Ikner, Luisa
Donskey, Curtis
Weber, David J.
Gerba, Chuck
author_facet Rutala, William A.
Ikner, Luisa
Donskey, Curtis
Weber, David J.
Gerba, Chuck
author_sort Rutala, William A.
collection PubMed
description BACKGROUND: Background: Contaminated hospital room environmental surfaces and noncritical medical devices are a potential source of transmission of healthcare pathogens including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Technologies that provide continuous decontamination between episodes of manual cleaning and disinfection could reduce the risk for transmission of SARS-CoV-2 from surfaces in rooms of coronavirus disease (COVID-19) patients. The aim of this study was to evaluate a continuously active disinfectant (CAD) that is registered by the Environmental Protection Agency (EPA) to kill microbes (including viruses) on surfaces for >24 hours. METHODS: Methods: We investigated the CAD against the human coronavirus, 229E, using the EPA “Protocol for Residual Self-Sanitizing Activity of Dried Chemical Residuals on Hard, Non-Porous Surfaces”. The method simulates contact and touches by incorporating “wear” of the test surface as well as re-inoculations of the test and control surfaces over at least 24 hours. The test surfaces were inoculated with ≥5-log10 per carrier, treated with the novel disinfectant, allowed to dry, and then abraded using a standardized abrasion machine under multiple alternating wet and dry wiping conditions (6 dry cycles, 6 wet cycles, total 12 cycles [2 passes per cycle=24 passes] each 24 hours) interspersed with 6 re-inoculations (or 12 re-inoculations in 48 hours) with ≥3.75-log10 of the test pathogen. After 24 or 48 hours, the surface was reinoculated with ≥5-log10 a final time, and the ability of the CAD to kill >99.9% of 229E with 1- or 5-minute contact times was measured on glass. RESULTS: Results: The CAD studied demonstrated excellent sustained antiviral activity (>4.0-log10 reduction) against 229E with 1- and 5-minute contact times after 24 and 48 hours. CONCLUSIONS: Conclusion: Based on our data using 229E, CAD may reduce or eliminate the role of contaminated environmental surfaces and noncritical equipment in transmission of SARS-CoV-2.
format Online
Article
Text
id pubmed-8236725
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-82367252021-06-28 Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E Rutala, William A. Ikner, Luisa Donskey, Curtis Weber, David J. Gerba, Chuck Am J Infect Control Ds 06 BACKGROUND: Background: Contaminated hospital room environmental surfaces and noncritical medical devices are a potential source of transmission of healthcare pathogens including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Technologies that provide continuous decontamination between episodes of manual cleaning and disinfection could reduce the risk for transmission of SARS-CoV-2 from surfaces in rooms of coronavirus disease (COVID-19) patients. The aim of this study was to evaluate a continuously active disinfectant (CAD) that is registered by the Environmental Protection Agency (EPA) to kill microbes (including viruses) on surfaces for >24 hours. METHODS: Methods: We investigated the CAD against the human coronavirus, 229E, using the EPA “Protocol for Residual Self-Sanitizing Activity of Dried Chemical Residuals on Hard, Non-Porous Surfaces”. The method simulates contact and touches by incorporating “wear” of the test surface as well as re-inoculations of the test and control surfaces over at least 24 hours. The test surfaces were inoculated with ≥5-log10 per carrier, treated with the novel disinfectant, allowed to dry, and then abraded using a standardized abrasion machine under multiple alternating wet and dry wiping conditions (6 dry cycles, 6 wet cycles, total 12 cycles [2 passes per cycle=24 passes] each 24 hours) interspersed with 6 re-inoculations (or 12 re-inoculations in 48 hours) with ≥3.75-log10 of the test pathogen. After 24 or 48 hours, the surface was reinoculated with ≥5-log10 a final time, and the ability of the CAD to kill >99.9% of 229E with 1- or 5-minute contact times was measured on glass. RESULTS: Results: The CAD studied demonstrated excellent sustained antiviral activity (>4.0-log10 reduction) against 229E with 1- and 5-minute contact times after 24 and 48 hours. CONCLUSIONS: Conclusion: Based on our data using 229E, CAD may reduce or eliminate the role of contaminated environmental surfaces and noncritical equipment in transmission of SARS-CoV-2. Published by Mosby, Inc. 2021-06 2021-06-28 /pmc/articles/PMC8236725/ http://dx.doi.org/10.1016/j.ajic.2021.04.015 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Ds 06
Rutala, William A.
Ikner, Luisa
Donskey, Curtis
Weber, David J.
Gerba, Chuck
Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title_full Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title_fullStr Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title_full_unstemmed Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title_short Antiviral Activity of a Continuously Active Disinfectant Against the Human Coronavirus 229E
title_sort antiviral activity of a continuously active disinfectant against the human coronavirus 229e
topic Ds 06
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236725/
http://dx.doi.org/10.1016/j.ajic.2021.04.015
work_keys_str_mv AT rutalawilliama antiviralactivityofacontinuouslyactivedisinfectantagainstthehumancoronavirus229e
AT iknerluisa antiviralactivityofacontinuouslyactivedisinfectantagainstthehumancoronavirus229e
AT donskeycurtis antiviralactivityofacontinuouslyactivedisinfectantagainstthehumancoronavirus229e
AT weberdavidj antiviralactivityofacontinuouslyactivedisinfectantagainstthehumancoronavirus229e
AT gerbachuck antiviralactivityofacontinuouslyactivedisinfectantagainstthehumancoronavirus229e